
JANUARY 2002
PYXIS® OVERRIDE POLICY
Safe medication practices promoted by national organizations and the JCAHO require pharmacist order review prior to medication administration. At KU Med Center, order reviewed by pharmacists result in 4000 to 6000 documented clinical interventions per month. These interventions include recommendations for alternate drug selection and order clarifications, to assure the correct dose, route, frequency, and rate. Except in emergent situations, it is important that all clarifications take place prior to drug administration. The importance of order review is heightened in the environment of an academic medical center. To ensure proper and reliable availability of medications, KU Med Center utilizes Pyxis® stations in the hospital for the access and distribution of many medications.
This newsletter summarizes the policy for medication order
processing and accessing medications from the Pyxis® system. The policy was
developed to maximize medication access while optimizing patient safety.
According to policy, all orders are faxed to the pharmacy and a pharmacist
reviews the order before it appears on the patient’s Pyxis® profile. Nurses
are able to access medications listed on the patient’s Pyxis® profile. In
cases of emergency, nurses may access a select group of medications via the
override function.
The Medication Distribution Process
Once new medication orders are faxed to the pharmacy, they are available from Pyxis® as soon as the order is entered into the pharmacy computer system and verified by pharmacists. Orders are triaged immediately upon receipt to the following categories of medication availability:
Status of Medications on the Pyxis® Patient Profile
The Pyxis® patient profile is like a "mini" real-time medication administration record (MAR). All of the medications that are active in the pharmacy computer system for a patient are on the Pyxis® profile. However, some of these medications may be "grayed-out". There are three reasons for a "gray-out" medication.
The Pyxis® Override Policy
The Pyxis® Override Policy allows access to a limited number of medications through the Pyxis® override function when clinical need for quick administration outweighs the safety and benefit of having a clinical pharmacist review the order. What medications are on the override list are not as important as the reasons that the medications are being accessed without going through the normal system that allows for review of orders. The surveyors reviewing JCAHO standard (TX 3.5.2) will most likely not be interested in seeing the list of medications, but instead may ask to see what has been overridden and ask for documentation of the situation that resulted in a need for the medication to be overridden.
The override list includes medications such as immediate release pain medications, anxiolytics, ACLS medications, neuromuscular blocking agents, intravenous steroids, and insulin.
The Pyxis® Override Policy and list were developed by the Nursing-Pharmacy Committee with review and approval by the Pharmacy and Therapeutics Committee and the Medical Staff Executive Committee. The Nursing-Pharmacy Committee can make additions to the override list as clinically indicated. Requests can be made by e-mailing Rick Couldry (
rcouldry@kumc.edu) or Brian O’Neal (boneal@kumc.edu). The request will be reviewed by the Nursing-Pharmacy Committee will then determine the necessity of the addition to the Pyxis® Override list. Requests must include: generic name, strength, dosage form, and a reason why the delay incurred with a pharmacist review of the medication may result in harm to the patient.Prepared by Antonia Zapantis, Pharm.D., Pharmacy Practice Management
12/18/01
![]()